Full Text View
Tabular View
No Study Results Posted
Related Studies
Pharmacokinetics Study of DPP-4 Inhibitor to Control Type 2 Diabetes Mellitus
This study is not yet open for participant recruitment.
Verified October 2011 by The Catholic University of Korea
Study NCT01449747   Information provided by The Catholic University of Korea

First Received on September 29, 2011.   Last Updated on October 7, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Type 2 Diabetes Mellitus
Additional conditions recognized in this trial
Diabetes Mellitus
Diabetes Mellitus, Type 2
More general conditions related to this trial
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
Sitagliptin
Additional drug interventions recognized in this trial
Dipeptidyl-Peptidase IV Inhibitors
More general drug interventions related to this trial
Enzyme Inhibitors
Hypoglycemic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protease Inhibitors
Sponsors listed in this trial
The Catholic University of Korea
Merck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services